►Home ►Site Index
TOPIGEN'S PRESIDENT AND CEO TO PRESENT AT BMO CAPITAL MARKETS' FOCUS ON HEALTHCARE CONFERENCE
TOPIGEN BEGINS IND-ENABLING STUDIES FOR TPI 1100 THE FIRST RNA-TARGETING COMPOUND TO TREAT COPD
TOPIGEN REPORTS POSITIVE THERAPEUTIC RESULTS FROM INITIAL PHASE II TRIAL STUDYING INHALED TPI ASM8
TOPIGEN INITIATES PHASE II PROGRAM OF TPI 1020 IN RESPIRATORY DISORDERS
TOPIGEN ANNOUNCES PRECLINICAL DATA AND ACCEPTANCE TO PRESENT AT THE AMERICAN THORACIC SOCIETY CONFERENCE
TOPIGEN SECURES US$6.0MM FINANCING FROM MMV FINANCIAL INC. - ADDITIONAL FUNDING TO ADVANCE RESPIRATORY PRODUCT PIPELINE
TOPIGEN’S CEO TO PRESENT AT BIO 2006 ANNUAL CHICAGO INTERNATIONAL CONVENTION BUSINESS FORUM
DR. MITCHELL GLASS JOINS TOPIGEN’S SCIENTIFIC ADVISORY BOARD
TOPIGEN CEO TO PRESENT AT SACHS ASSOCIATES 5TH ANNUAL NORTH AMERICAN FORUM
TOPIGEN’S CEO TO PRESENT AT BIO CEO & INVESTOR CONFERENCE
2008 Archives 2007Archives 2005